Skip to content

Jazz Pharmaceuticals JAZZ Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Efficiency
Asset turnover0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Liquidity
Current ratio-1.3×1.9×-2.6×1.7×-2.6×1.6×-0.7×3.4×+1.1×
Leverage
Debt-to-equity1.2×-0.1×1.3×-0.2×1.4×-0.1×1.5×-0.1×1.3×-0.3×
Per Share
Book value per share$68.57+0.2%$70.82+14.2%$64.26-2.7%$60.57+12.1%$68.44+15.8%
Valuation
Market capitalization$11.64B+54.4%$10.33B+38.8%$7.99B+14.1%$6.54B-2.0%$7.54B+0.1%
Price / sales2.6×+0.8×2.4×+0.6×1.9×+0.2×1.6×-0.1×1.9×-0.1×
Price / book2.6×+0.8×2.4×+0.6×+0.3×1.8×0.0×1.8×-0.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Jazz Pharmaceuticals's ratios come from?
Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.